ストックスクリーナーアプリを入手
43.57
2.21%
0.94
アフターアワーズ：
44.00
0.43
+0.99%
前日終値:
$42.63
開ける：
$42.66
24時間の取引高:
2.57M
Relative Volume:
0.82
時価総額：
$6.36B
収益：
$10.12M
当期純損益:
$-280.49M
株価収益率:
-15.08
EPS:
-2.89
ネットキャッシュフロー:
$-188.51M
1週間 パフォーマンス:
+3.00%
1か月 パフォーマンス:
-6.46%
6か月 パフォーマンス:
+47.59%
1年 パフォーマンス:
-5.14%
1日の値動き範囲:
$42.26
$43.69
1週間の範囲:
$38.94
$44.50
52週間の値動き範囲:
$21.51
$56.00
Avidity Biosciences Inc Stock (RNA) Company Profile
名前
Avidity Biosciences Inc
セクター
電話
858-401-7900
住所
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
RNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RNA
Avidity Biosciences Inc
|
43.57 | 6.22B | 10.12M | -280.49M | -188.51M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-17 | 開始されました | Roth Capital | Buy |
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2025-06-24 | 開始されました | Bernstein | Outperform |
| 2025-06-17 | 開始されました | Wolfe Research | Outperform |
| 2025-06-11 | 開始されました | Raymond James | Strong Buy |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-09-24 | 開始されました | Goldman | Buy |
| 2024-08-28 | 開始されました | Barclays | Overweight |
| 2024-05-03 | 開始されました | BofA Securities | Buy |
| 2024-03-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-05-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-03-31 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-07-20 | 開始されました | Chardan Capital Markets | Buy |
| 2022-07-12 | 開始されました | Raymond James | Strong Buy |
| 2021-09-07 | 開始されました | Evercore ISI | Outperform |
| 2021-06-17 | 開始されました | Needham | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2020-07-07 | 開始されました | Cowen | Outperform |
| 2020-07-07 | 開始されました | Credit Suisse | Outperform |
| 2020-07-07 | 開始されました | SVB Leerink | Outperform |
| 2020-07-07 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Avidity Biosciences Inc (RNA) 最新ニュース
Avidity Biosciences (NASDAQ:RNA) Shares Down 7.6%Here's What Happened - MarketBeat
Relative strength of Avidity Biosciences Inc. in sector analysisMarket Rally & Long-Term Growth Stock Strategies - newser.com
Avidity Biosciences Inc. stock trendline breakdownJuly 2025 Macro Moves & Free Technical Pattern Based Buy Signals - newser.com
Can Avidity Biosciences Inc. stock hit record highs againJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Avidity Biosciences, Inc. (RNA) Stock Analysis: A Promising Biotech Play with 58.58% Potential Upside - DirectorsTalk Interviews
Avidity Biosciences, Inc. (RNA) Stock Analysis: A Potent 58.58% Upside In Biotech - DirectorsTalk Interviews
Quantitative breakdown of Avidity Biosciences Inc. recent moveWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Combining machine learning predictions for Avidity Biosciences Inc.Portfolio Return Summary & Weekly High Return Stock Opportunities - newser.com
Real time scanner hits for Avidity Biosciences Inc. explainedJuly 2025 Weekly Recap & Stock Portfolio Risk Control - newser.com
Why Momentum Traders Are Watching Shigan Quantum Technologies Limited Stock CloselyDebt-to-Equity Ratio Analysis & Ride the Trends That Billionaires Follow - earlytimes.in
Assenagon Asset Management S.A. Has $507,000 Position in Avidity Biosciences, Inc. $RNA - MarketBeat
Ranking Avidity Biosciences Inc. among high performing stocks via toolsQuarterly Portfolio Summary & Proven Capital Preservation Tips - newser.com
Avidity Biosciences (RNA) Announces Positive One-Year Data For its, Del-Zota - Yahoo Finance
Avidity Biosciences (NASDAQ:RNA) Insider Sells $89,600.64 in Stock - MarketBeat
Evercore Maintains Avidity Biosciences(RNA.US) With Buy Rating, Cuts Target Price to $65 - 富途牛牛
Analysts Issue Forecasts for RNA Q3 Earnings - MarketBeat
Avidity Biosciences Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Evercore ISI Group Lowers Price Target for Avidity Biosciences (RNA) to $65 | RNA Stock News - GuruFocus
Evercore ISI Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00 - MarketBeat
Repare Therapeutics (NASDAQ:RPTX) versus Avidity Biosciences (NASDAQ:RNA) Head to Head Contrast - Defense World
Mirador Capital Partners LP Grows Stock Position in Avidity Biosciences, Inc. $RNA - MarketBeat
Can Avidity Biosciences Inc. hit a new high this monthMarket Performance Recap & Reliable Price Breakout Alerts - newser.com
Voya Investment Management LLC Cuts Stock Position in Avidity Biosciences, Inc. $RNA - MarketBeat
Avidity Biosciences prices $600M stock offering - MSN
Aug Big Picture: Can Avidity Biosciences Inc. maintain sales growth2025 Technical Patterns & Detailed Earnings Play Strategies - khodrobank.com
What is Roth Capital’s Estimate for RNA Q3 Earnings? - Defense World
Roth MKM Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $62 - 富途牛牛
First Week of November 21st Options Trading For Avidity Biosciences (RNA) - Nasdaq
Avidity Biosciences (NASDAQ:RNA) Stock Price Down 5.3%Here's What Happened - MarketBeat
Bank of America Increases Avidity Biosciences (NASDAQ:RNA) Price Target to $65.00 - MarketBeat
Investor Mood: Is Pamt Corp. currently under institutional pressureMarket Volume Summary & Weekly Watchlist of Top Performers - khodrobank.com
Analyst Calls: What hedge funds are buying Avidity Biosciences IncJuly 2025 Reactions & High Win Rate Trade Tips - خودرو بانک
Breakouts Watch: Should value investors consider Avidity Biosciences Inc2025 Dividend Review & Precise Swing Trade Alerts - khodrobank.com
Avidity (RNA) Jumps 9.2% on Drug Candidate’s Breakthrough Therapy Designation - MSN
Avidity Biosciences (NASDAQ:RNA) Coverage Initiated by Analysts at Roth Capital - MarketBeat
Aug Mood: Will HRZN be affected by tariffs2025 Dividend Review & Daily Stock Momentum Reports - khodrobank.com
Aug Chart Watch: What makes Avidity Biosciences Inc. stock attractive todayTreasury Yields & Advanced Swing Trade Entry Plans - خودرو بانک
Avidity Biosciences’ SWOT analysis: promising pipeline drives stock outlook - Investing.com
Growth Value: Is Avidity Biosciences Inc. stock showing strong momentumJuly 2025 Breakouts & Free Safe Entry Trade Signal Reports - khodrobank.com
Roth Capital Initiates Coverage of Avidity Biosciences (RNA) with Buy Recommendation - Nasdaq
Avidity Biosciences CMO sells $70k in shares - Investing.com
Avidity Biosciences (RNA) Gets 9% Boost from Higher PT, Rating - MSN
Avidity Biosciences Stock Hits Day Low of $39.83 Amid Price Pressure - Markets Mojo
Roth Capital Initiates Coverage on RNA with a 'Buy' Rating | RNA Stock News - GuruFocus
Decliners Report: Can Avidity Biosciences Inc continue delivering strong returnsMarket Risk Analysis & Free Risk Controlled Daily Trade Plans - خودرو بانک
Roth Capital Partners Initiates Avidity Biosciences at Buy - MarketScreener
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Eastern Progress
Roth/MKM initiates Avidity Biosciences stock with Buy rating on platform potential - Investing.com
Avidity Biosciences (NASDAQ:RNA) Shares Gap Up on Analyst Upgrade - MarketBeat
Downgrade Watch: Is Avidity Biosciences Inc. a cyclical or defensive stockJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - khodrobank.com
Avidity Biosciences (NASDAQ:RNA) Shares Gap DownShould You Sell? - MarketBeat
Avidity Biosciences Inc (RNA) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):